The drugmaker’s move responded to the growing competition that has shaken up the insulin market in recent years.
- Dean of the Sol Price School of Public Policy; Distinguished Professor of Pharmacy, Public Policy, and Economics, University of Southern California
Medical innovations paired with innovative programs to get them to Black, Indigenous and Hispanic Americans can help close the health inequality gap.
A team of experts argues that after taking care of essential workers, COVID-19 vaccinations should be given to the greatest transmitters of the virus, who are mostly the young.
Nearly 40% of Americans are obese, and the numbers are climbing. The U.S. needs to get serious about solutions.
Nearly 160 million Americans get insurance through employers, but that does not mean it’s good social policy. An economist explains some aspects of employer-sponsored insurance that don’t work well.
The Orphan Drug Act was enacted 34 years ago to encourage the development of drugs for rare diseases. Drug companies were guaranteed seven years of exclusivity. Then the rush was on to run up prices.
Academics are trained to answer important questions about health policy, and collaborating with industry on research can have a big impact.
Contact Dana for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: Los Angeles, California, U.S.
- Website
- X (formerly Twitter): @DanaGol38751110
- Article Feed
- ORCID
- Joined
